Clinical Trial Update: The SOLID Platelet Study [Phase 2]

View source ↗

Summary

Phase 2 SOLID Platelet Study investigating therapies for platelet transfusion refractoriness and thrombocytopenia has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Platelet Transfusion Refractoriness
• Thrombocytopenia

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Platelet Transfusion Refractoriness (PTR), Thrombocytopenia | Phase 2 | Status: TERMINATED | Results posted: 2025-05-09